Trump’s Final Shocking Act Begins February 24

It's not because he's sick or having any health issues. ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­

Dear Reader,

After signing more than 220 Executive Orders… more than any president in American history… Donald Trump is preparing for one final move.

On February 24th — I have every reason to believe he will sign his Final Executive Order.

When I say that it’s his FINAL executive order…

It’s not because he’s leaving office.

It’s not because he’s sick or having any health issues.

It’s not because he’ll be impeached for the Epstein files, or some dark, twisted scandal.

There’s another reason that, despite a long future in front of him, this will be Trump’s very last Executive Order…

Click here or below for this unbelievable story…

Regards,

Ian King
Chief Strategist, Strategic Fortunes

Your interaction with our content, in any format, is appreciated. We value your time and the trust you place in our communications. Thank you for being an active member of our community, and we look forward to continued exchanges in the future. Privacy Policy MarketBeat ("the Company") values the privacy of visitors to MarketBeat site and users of our services. This notice explains how we collect, use, and protect information. Why You're Receiving This Email You're receiving this email because at some point, you opted in to receive updates, news, or information on a specific topic we've previously discussed or shared. Whether it was through a subscription, a form submission, or another form of communication, your information was shared willingly, and we respect your decision to connect with us. Thank you for taking the time to read this email. This message is part of an ongoing conversation between us, and I want to take a moment to ensure you have full transparency about why you received this message, how your information is handled, and what to expect from future emails. If you're wondering about the nature of our correspondence, rest assured that we aim to keep all emails relevant, timely, and from unnecessary clutter. This includes respecting your inbox and refraining from sending irrelevant messages. A Commitment to Non-Intrusive Emails We aim to create a non-intrusive communication experience. This means we won't overwhelm your inbox with excessive messages, and we work hard to ensure our content remains clear and concise. The purpose of this email is to stay connected with you and provide updates or information that we believe is meaningful. If we ever fail to meet these standards, we encourage you to let us know. Feedback, whether positive or constructive, is always appreciated. Your thoughts help us understand how we can do better and improve our communication approach. While we cannot promise every suggestion will be implemented, we will take the time to carefully review and consider your input. Accessibility and Communication If you have any trouble accessing the unsubscribe page, managing preferences, or understanding why you're receiving this email, you can reach out directly to our support team. We aim to provide a response within a reasonable time frame and address your concerns effectively. Our communication is designed to be as inclusive as possible, but we know there's always room for improvement. If you have any feedback on how we can make our emails more accessible or relevant, please don't hesitate to share. Your Privacy is Important We value your trust and take your privacy very seriously. The information you provide is securely stored and never shared, sold, or used outside the purpose for which you provided it. This privacy policy describes how we collects, uses, and protects your information. We collect information you voluntarily provide, such as your name, email address, or phone number. We may also collect technical data from your visit, including browser type, operating system, and your IP address. We use this information to respond to your inquiries, provide access to services, and improve our communications. We do not share your information with unrelated third parties. Some of our services may use third-party tools that store or process data on our behalf. These tools are selected with care and are expected to maintain data responsibly. We do not knowingly collect personal information from children under 13 years of age. If we discover that such information was provided without parental consent, we will delete it promptly. You can request to update or delete your personal information by contacting us. We may update this privacy policy occasionally. Changes will be reflected on the page. Orders with MarketBeat are handled using secure processes. If there is a need to update delivery details, someone from our team may contact you. Please note, we do not ask for personal payment information by email. You can enable extra sign-in protection and use strong security to help keep you safe. We regularly review our systems and follow best practices to help protect your information. If you notice anything unusual, it may be helpful to review your settings. Transparency is our priority, and we're happy to address any questions you might have. How to Unsubscribe or Manage Your Preferences We understand that everyone's inbox is different. If you ever find our emails no longer relevant, there's no hard feelings. You can easily manage your email preferences or unsubscribe using the link provided below. By clicking the unsubscribe link, you'll be taken to a page where you can either adjust your communication preferences (such as receiving fewer emails or only on specific topics) or completely remove yourself from our list. The process is straightforward, and any changes will take effect promptly. We don't use tricks or gimmicks to keep you subscribed. Our priority is to ensure that our emails add value to your day, and if they don't, we respect your decision to part ways. Legal Information We comply with all applicable laws and regulations regarding email communication. This includes adhering to laws and maintaining the highest standards for consent-based communication. Your trust matters, and we work diligently to ensure every email you receive meets these requirements. If you need further clarification on our compliance policies or legal obligations, please ask. Transparency and accountability are central to our communication strategy, and we're happy to provide additional details if needed. Contact Information We strive to ensure all communication channels are open and readily available to you. Whether it's a question, comment, or concern, our team is ready to assist. For assistance, please contact our team via email by replying to this email. A Final Note Emails are one of the many ways we stay connected, but we understand they aren't perfect for everyone. If there's another way you'd prefer to communicate or stay updated, let us know. Whether it's through social media, a direct call, or another channel, we're open to finding the most effective way to share information with you. We want to emphasize that our goal is never to disrupt or clutter your inbox. Every email sent is intended to provide value, and we genuinely appreciate your time and attention. This footer was designed to ensure transparency, provide essential information, and give you full control over your communication preferences. We hope it meets your expectations, but if there's anything you'd like to see improved, we're always here to listen. Best regards, MarketBeat

 
 
 
 
 
 

---

Exclusive News

Intuitive Surgical Just Proved the Growth Engine Still Runs

Submitted by Leo Miller. Article Posted: 1/23/2026.

Article Highlights

• Intuitive Surgical’s Q4 2025 results beat on both revenue and EPS, reinforcing confidence in its robotics‑assisted surgery leadership despite a deceleration in procedure growth.
• Guidance for 2026 shows steady procedural demand and gross margins, with investment in R&D and new platforms (Ion, da Vinci SP) supporting long‑term growth prospects.
• Tariff headwinds and a high valuation present near‑term risks, but investor resilience and market trust underpin sustained growth expectations.

Robotic-assisted surgery stalwart Intuitive Surgical (NASDAQ: ISRG) stunned investors with its Q3 2025 earnings report in October 2025. Shares closed up nearly 14% on that news, marking the healthcare stock's largest single-day post-earnings gain in recent memory.

On Jan. 22, the company reported its Q4 2025 results. While they didn't generate the same level of excitement as the prior quarter, the market received the release positively — the stock rose about 1.4% in after-hours trading. Despite a lofty valuation, Intuitive maintains a constructive long-term outlook and appears capable of keeping its growth engine running.

Intuitive Beats on Revenue and EPS By a Solid Margin

Did the government just make a $500 trillion mistake? (Ad)

A little-known government task force just wrapped up a 20-year project, and its findings could unlock access to a massive U.S. national asset. Under existing law, everyday Americans may now have a legal path to participate in what some are calling a once-in-a-generation opportunity.

Details are still flying under the radar, but that may not last.

See the full briefing and how it works

In Q4, Intuitive posted revenue of $2.87 billion, up 19% year over year, comfortably above estimates of $2.72 billion (13% growth). The adjusted earnings per share (EPS) beat was notable as well: adjusted EPS came in at $2.53, up just over 14%, versus analysts' expectations of $2.25 (less than 2% growth).

Growth in da Vinci procedures is a key performance indicator for Intuitive. More procedures performed by doctors typically drive purchases of disposable instruments, which are an important source of recurring revenue and usually account for the majority of total sales.

Da Vinci procedures rose 17% in the quarter, within the company's typical range over the past two years, though slightly below the 19% growth recorded last quarter. For the full year, da Vinci procedures increased by 18%.

Intuitive Provides Solid Guidance, But Growth May Decelerate

Looking to 2026, the company expects da Vinci procedure growth of 14% at the midpoint. Note that Intuitive does not provide an explicit revenue growth forecast, but revenue growth often moves in the same direction as da Vinci procedure growth. Management expects gross margin of 67% to 68% in 2026, roughly in line with 2025's 67.7%.

Intuitive also expects operating expenses to rise slightly faster in 2026 than in 2025, which could compress operating margin if revenue growth slows along with procedure growth. Management attributes the higher expense growth in part to early-stage research and development investments.

While those investments could be dilutive in the near term, they support the company's long-term prospects. Sustained growth will depend on developing new devices and platforms and expanding approvals for current offerings. The company's Ion and da Vinci SP platforms are examples of potential new growth drivers: procedures for those systems increased 78% and 51%, respectively, during the quarter.

Markets Look Past Intuitive's Tariff Guidance, Mitigating a Key Headwind

Importantly, investors appeared unfazed by Intuitive's tariff-related guidance. For 2026, the firm expects tariffs to reduce gross margins by about 1.2%, significantly higher than the roughly 65-basis-point impact in 2025. That shares held up despite this is a positive sign: tariff concerns had weighed on the stock through much of 2025, and clearer disclosure of tariff exposure reduces uncertainty for investors.

Intuitive Surgical is not inexpensive — it trades at a forward price-to-earnings (P/E) ratio near 56x — but it has established a leadership position in robot-assisted surgery and earned trust across the healthcare industry. That trust should help as the company expands into new markets and competes against challengers. Still, management will need to keep innovating and delivering strong procedure growth to justify the current valuation and support further gains in the stock price.

 

 
This email communication is a sponsored email sent on behalf of Banyan Hill Publishing, a third-party advertiser of MarketBeat. Why did I receive this email content?.
 
 
If you would like to unsubscribe from receiving offers for Strategic Fortunes, please click here.
 
 
If you have questions about your subscription, please email our U.S. based support team at contact@marketbeat.com.
 
If you would no longer like to receive promotional emails from MarketBeat advertisers, you can unsubscribe or manage your mailing preferences here.
 
© 2006-2026 MarketBeat Media, LLC.
345 N Reid Pl., Suite 620, Sioux Falls, SD 57103. United States..

 

Further Reading: The day the gold market broke (From Behind the Markets)